The aim of the study was to assess salivary and serum concentrations of chemerin, α-defensin 1 and TNF-α in CRC patients and to compare them with the concentrations found in healthy subjects, which could demonstrate that these proteins could be potential diagnostic markers in CRC. The gene discussed is RARRES2; the disease is colorectal carcinoma.